Dr Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar, Manipal 576 104, Karnataka, India.
Dr Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India.
Bioorg Chem. 2019 Oct;91:103155. doi: 10.1016/j.bioorg.2019.103155. Epub 2019 Jul 29.
The chorismate mutase (CM) is considered as an attractive target for the identification of potential antitubercular agents due to its absence in animals but not in bacteria. A series of 3-indolylmethyl substituted pyrazolotriazinone derivatives were designed and docked into CM in silico as potential inhibitors. These compounds were efficiently synthesized using the Pd/Cu-catalyzed coupling-cyclization in a single pot involving the construction of indole ring. The methodology was later extended to the preparation of corresponding benzo analogs of pyrazolotriazinones i.e. 3-indolylmethyl substituted benzotriazinone derivatives. Several of these novel compounds showed significant inhibition of CM when tested in vitro at 30 µM. The SAR (Structure-Activity-Relationship) studies suggested that benzotriazinone moiety was more favorable over the pyrazolotriazinone ring. The two best active compounds showed IC ∼ 0.4-0.9 µM (better than the reference/known compounds used) and no toxicity till 30 µM in vitro.
分支酸变位酶(CM)被认为是鉴定潜在抗结核药物的有吸引力的靶标,因为它在动物中不存在,但在细菌中存在。设计了一系列 3-吲哚甲基取代的吡唑并三嗪酮衍生物,并在计算机上将其对接入 CM 中作为潜在的抑制剂。这些化合物使用 Pd/Cu 催化的偶联-环化在一锅法中高效合成,涉及吲哚环的构建。该方法后来扩展到相应的苯并类似物吡唑并三嗪酮的制备,即 3-吲哚甲基取代的苯并三嗪酮衍生物。当在 30µM 下进行体外测试时,这些新型化合物中的几种显示出对 CM 的显著抑制作用。SAR(构效关系)研究表明,苯并三嗪酮部分比吡唑并三嗪酮环更有利。两个最有效的化合物表现出 IC ~ 0.4-0.9µM(优于所用的参考/已知化合物),在 30µM 下体外无毒性。